SI
Sofinnova Investments’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-46,386
| Closed | -$4.03M | – | 69 |
|
2021
Q2 | $4.03M | Sell |
46,386
-8,409
| -15% | -$730K | 0.23% | 52 |
|
2021
Q1 | $4.52M | Buy |
54,795
+41,298
| +306% | +$3.41M | 0.27% | 47 |
|
2020
Q4 | $1.23M | Sell |
13,497
-27,903
| -67% | -$2.54M | 0.07% | 58 |
|
2020
Q3 | $1.65M | Buy |
+41,400
| New | +$1.65M | 0.12% | 57 |
|
2020
Q2 | – | Sell |
-36,564
| Closed | -$812K | – | 72 |
|
2020
Q1 | $812K | Sell |
36,564
-598,579
| -94% | -$13.3M | 0.08% | 56 |
|
2019
Q4 | $12.4M | Buy |
635,143
+253,543
| +66% | +$4.96M | 0.9% | 25 |
|
2019
Q3 | $5.93M | Buy |
+381,600
| New | +$5.93M | 0.54% | 37 |
|
2019
Q2 | – | Sell |
-203,742
| Closed | -$3.58M | – | 68 |
|
2019
Q1 | $3.58M | Sell |
203,742
-26,071
| -11% | -$458K | 0.35% | 43 |
|
2018
Q4 | $2.95M | Buy |
229,813
+124,922
| +119% | +$1.6M | 0.37% | 47 |
|
2018
Q3 | $1.71M | Buy |
+104,891
| New | +$1.71M | 0.15% | 52 |
|